AJP - Renal Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 282: F639-F648, 2002. First published October 16, 2001; doi:10.1152/ajprenal.00189.2001
0363-6127/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/4/F639    most recent
00189.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (37)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zheng, F.
Right arrow Articles by Striker, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zheng, F.
Right arrow Articles by Striker, G. E.
Vol. 282, Issue 4, F639-F648, April 2002

Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation

Feng Zheng1, Alessia Fornoni1, Sharon J. Elliot1, Youfei Guan2, Matthew D. Breyer2, Liliane J. Striker1, and Gary E. Striker1

1 Vascular Biology Institute and Division of Nephrology, Department of Medicine, University of Miami School of Medicine, Miami, Florida 33136; and 2 Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Vanderbilt, Tennessee 37232

We found that peroxisome proliferator-activated receptor-gamma (PPARgamma ) mRNA was reduced by 77% in glomeruli of diabetic mice. Because mesangial cells play an important role in diabetic nephropathy, we examined regulation of type I collagen expression by PPARgamma and transforming growth factor-beta 1 (TGF-beta 1) in mouse mesangial cells in the presence of 6 and 25 mM glucose. Mesangial cells contained functionally active PPARgamma . Exposure to 25 mM glucose resulted in reduced PPARgamma expression and transcriptional activity, accompanied by increased type I collagen expression. Restoration of PPARgamma activity to normal levels in cells cultured in 25 mM glucose, by transfection with a PPARgamma expression construct and treatment with the PPARgamma agonist troglitazone, returned type I collagen levels toward normal values. Activation of PPARgamma by troglitazone also decreased type I collagen mRNA and blocked TGF-beta 1-mediated upregulation of type I collagen mRNA and protein. Moreover, PPARgamma activation suppressed basal and activated TGF-beta 1 responses in mesangial cells. This action was blocked by transfection of cells with a dominant-negative PPARgamma construct. In summary, PPARgamma suppresses the increased type I collagen mRNA and protein expression mediated by TGF-beta 1 in mesangial cells.

peroxisome proliferator-activated receptor-gamma ; transforming growth factor-beta 1; diabetic nephropathy


This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. E. Milam, V. G. Keshamouni, S. H. Phan, B. Hu, S. R. Gangireddy, C. M. Hogaboam, T. J. Standiford, V. J. Thannickal, and R. C. Reddy
PPAR-{gamma} agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis
Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L891 - L901.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
X. Ruan, F. Zheng, and Y. Guan
PPARs and the kidney in metabolic syndrome
Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1032 - F1047.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
R. Mishra and M. S. Simonson
Oleate Induces a Myofibroblast-Like Phenotype in Mesangial Cells
Arterioscler. Thromb. Vasc. Biol., March 1, 2008; 28(3): 541 - 547.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
R. Mishra, L. Zhu, R. L. Eckert, and M. S. Simonson
TGF-beta-regulated collagen type I accumulation: role of Src-based signals
Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1361 - C1369.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
S. Ohga, K. Shikata, K. Yozai, S. Okada, D. Ogawa, H. Usui, J. Wada, Y. Shikata, and H. Makino
Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-{kappa}B activation
Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1141 - F1150.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. J. Wang, S. X. Zhang, R. Mott, R. R. Knapp, W. Cao, K. Lau, and J.-x. Ma
Salutary Effect of Pigment Epithelium-Derived Factor in Diabetic Nephropathy: Evidence for Antifibrogenic Activities
Diabetes, June 1, 2006; 55(6): 1678 - 1685.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
Y. Li, X. Wen, B. C. Spataro, K. Hu, C. Dai, and Y. Liu
Hepatocyte Growth Factor Is a Downstream Effector that Mediates the Antifibrotic Action of Peroxisome Proliferator-Activated Receptor-{gamma} Agonists
J. Am. Soc. Nephrol., January 1, 2006; 17(1): 54 - 65.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
Y. Guan
Peroxisome Proliferator-Activated Receptor Family and Its Relationship to Renal Complications of the Metabolic Syndrome
J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2801 - 2815.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
F. Zheng, A. R. Plati, M. Potier, Y. Schulman, M. Berho, A. Banerjee, B. Leclercq, A. Zisman, L. J. Striker, and G. E. Striker
Resistance to Glomerulosclerosis in B6 Mice Disappears after Menopause
Am. J. Pathol., April 1, 2003; 162(4): 1339 - 1348.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online